Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (9) · 1314-1315
DOI: 10.1111/apt.70586 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 06.03.2026. Verfasst von Daniel Q Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore.
- Dr. Mary and Ron Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas, USA.
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
- Weill Cornell Medicine, Cornell University, New York, New York, USA.
ORCID-Profile: Daniel Q Huang
Zitieren
APA
Huang, D. Q., Pham, Y. T., & Luu, H. N. (2026). Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(9), 1314-1315. https://doi.org/10.1111/apt.70586
Vancouver
Huang DQ, Pham YT, Luu HN. Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(9):1314-1315. doi:10.1111/apt.70586
BibTeX
@article{Huang2026,
author = {Huang, Daniel Q and Pham, Yen Thi-Hai and Luu, Hung N},
title = {Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {9},
pages = {1314--1315},
doi = {10.1111/apt.70586}
}
EUVIMED